{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:35:09Z","timestamp":1760729709897,"version":"3.33.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3652,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominantly inherited disorder characterized by cutaneous and mucosal telangiectasias, epistaxis and arteriovenous malformations in lung, liver, central nervous system, and gastrointestinal tract. Mutations in the genes for endoglin (ENG) and for activin A receptor type II-like kinase 1 (ALK-1) have been identified to be associated with HHT. Intrahepatic manifestation in HHT might lead to the requirement of liver transplantation. We report here on 6 liver transplanted patients and 2 who were scheduled for liver transplantation due to intrahepatic HHT, in whom both genes were sequenced. Mutation analysis revealed in all patients the presence of mutations in ALK-1. In conclusion, these results are of possible prognostic value concerning the need of liver transplantation in HHT patients.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20544","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T17:48:53Z","timestamp":1124992133000},"page":"1132-1135","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["ALK-1 Mutations in Liver Transplanted Patients With Hereditary Hemorrhagic Telangiectasia"],"prefix":"10.1097","volume":"11","author":[{"given":"Loukas","family":"Argyriou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Pfitzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-Erik","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Twelkemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Nayernia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20250124","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jmg.40.8.585","article-title":"Hereditary haemorrhagic telangiectasia: A questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.","volume":"40","author":"Berg","year":"2003","journal-title":"J Med Genet"},{"key":"R2-19-20250124","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ultrasmedbio.2004.08.004","article-title":"High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia.","volume":"30","author":"Buscarini","year":"2004","journal-title":"Ultrasound Med Biol"},{"key":"R3-19-20250124","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2004-813549","article-title":"Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia results of extensive screening.","volume":"25","author":"Buscarini","year":"2004","journal-title":"Ultraschall Med"},{"key":"R4-19-20250124","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00004728-200407000-00009","article-title":"Hepatic involvement in hereditary hemorrhagic telangiectasia: Helical computed tomography features in 24 consecutive patients.","volume":"28","author":"Ravard","year":"2004","journal-title":"J Comput Assist Tomogr"},{"key":"R5-19-20250124","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/jmg.40.7.494","article-title":"Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.","volume":"40","author":"Abdalla","year":"2003","journal-title":"J Med Genet"},{"key":"R6-19-20250124","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1136\/jmg.39.7.e39","article-title":"Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia.","volume":"39","author":"Olivieri","year":"2002","journal-title":"J Med Genet"},{"key":"R7-19-20250124","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/humu.9311","article-title":"Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.","volume":"25","author":"Kuehl","year":"2005","journal-title":"Hum Mutat"},{"key":"R8-19-20250124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","article-title":"Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion.","volume":"15","author":"den Dunnen","year":"2000","journal-title":"Hum Mutat"},{"key":"R9-19-20250124","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1183\/09031936.04.00085504","article-title":"Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.","volume":"23","author":"Abdalla","year":"2004","journal-title":"Eur Respir J"},{"key":"R10-19-20250124","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1091\/mbc.12.9.2881","article-title":"Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor.","volume":"12","author":"Garamszegi","year":"2001","journal-title":"Mol Biol Cell"},{"key":"R11-19-20250124","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/513903","article-title":"The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.","volume":"61","author":"Berg","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R12-19-20250124","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00007890-200107270-00012","article-title":"Liver transplantation for treatment of intrahepatic Oslers disease: first experiences.","volume":"72","author":"Pfitzmann","year":"2001","journal-title":"Transplantation"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20544","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200509000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:01:45Z","timestamp":1737734505000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200509000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20544","relation":{},"ISSN":["1527-6465"],"issn-type":[{"type":"print","value":"1527-6465"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}